Chicago-based CRISPR technology company Syntax Bio says it has developed tech which automates the slow, manual process of ...
Programmable CRISPR tools are turning stem cell biology into something closer to software engineering, shrinking ...
Dyadic International, Inc. ( DYAI) IAccess Alpha Virtual Best Ideas Winter Investment Conference 2025 December 9, 2025 9:30 AM EST Good day, and welcome to the iAcessAlpha Virtual Best Ideas winter ...
A groundbreaking new treatment using genome-edited immune cells, developed by scientists at UCL (University College London) ...
A cutting-edge base-edited CAR T-cell therapy is opening a revolutionary new frontier for patients battling aggressive T-cell ...
The genetically engineered food is also protein packed and sustainable, say scientists. Chinese researchers used gene-editing ...
This year, gene-editing technology was customized to fix mutations in a single patient’s genes for the first time.
Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced the publication of ...
Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced the publication of new research in Science Advances detailing the company’s CRISPR-based ...
Syntax Bio, a synthetic biology company programming the next generation of cell therapies, has published new research in ...
Scientists grew a microscopic fungus into a more efficient — and meat-like — edible protein by tweaking just two genes with ...